US Stock MarketDetailed Quotes

PRQR ProQR Therapeutics

Watchlist
  • 1.6500
  • +0.0200+1.23%
Close Mar 21 16:00 ET
  • 1.6400
  • -0.0100-0.61%
Post 20:01 ET
173.60MMarket Cap-4.76P/E (TTM)

ProQR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-268.89%-36.39M
-75.65%-9.35M
24.65%-5.66M
39.54%-6.26M
-133.83%-15.13M
131.45%21.55M
70.16%-5.32M
51.13%-7.51M
30.30%-10.35M
318.52%44.73M
Net income from continuing operations
-0.10%-27.76M
-69.71%-9.31M
-49.59%-8.11M
66.25%-2.69M
13.52%-7.66M
56.80%-27.74M
58.77%-5.48M
76.74%-5.42M
40.84%-7.98M
37.27%-8.86M
Operating gains losses
68.17%-345K
-104.11%-79K
91.34%-139K
11.76%-195K
110.15%68K
59.93%-1.08M
209.52%1.92M
-140.01%-1.61M
-256.45%-221K
82.16%-670K
Depreciation and amortization
9.87%2.76M
-7.83%671K
7.17%688K
19.70%711K
25.87%691K
-0.32%2.51M
-2.67%728K
4.90%642K
0.51%594K
-3.68%549K
Deferred tax
-152.56%-197K
--0
--0
---200K
--3K
-181.25%-78K
--5K
-220.29%-83K
--0
--0
Other non cash items
53.31%-2.81M
76.64%-1.34M
-29.20%-469K
10.16%-513K
-458.82%-488K
-463.48%-6.01M
-320.62%-5.72M
39.40%-363K
75.25%-571K
-83.45%136K
Change In working capital
-127.09%-13.26M
-123.65%-543K
155.63%1.12M
-27.39%-4.61M
-117.64%-9.22M
1,080.89%48.96M
141.27%2.3M
-155.67%-2.01M
-495.41%-3.62M
1,423.80%52.29M
-Change in other working capital
-127.09%-13.26M
-123.65%-543K
155.63%1.12M
-27.39%-4.61M
-117.64%-9.22M
1,080.89%48.96M
141.27%2.3M
-155.67%-2.01M
-495.41%-3.62M
1,423.80%52.29M
Cash from discontinued investing activities
Operating cash flow
-268.89%-36.39M
-75.65%-9.35M
24.65%-5.66M
39.54%-6.26M
-133.83%-15.13M
131.45%21.55M
70.16%-5.32M
51.13%-7.51M
30.30%-10.35M
318.52%44.73M
Investing cash flow
Cash flow from continuing investing activities
-195.21%-4.07M
-155.76%-2.79M
5,030.38%16.71M
9.18%-267K
-19,823.60%-17.73M
709.40%4.28M
26,215.79%5M
-37.80%-339K
-27.27%-294K
63.52%-89K
Net PPE purchase and sale
-8.16%-1.42M
77.42%-133K
15.63%-286K
9.18%-267K
-722.47%-732K
-86.75%-1.31M
-3,200.00%-589K
-37.80%-339K
-27.27%-294K
63.52%-89K
Net intangibles purchase and sale
--0
----
----
----
----
--7.94M
----
----
----
----
Net investment purchase and sale
--0
--0
--17M
--0
---17M
--0
--0
--0
--0
--0
Net other investing changes
-12.93%-2.66M
----
----
----
----
---2.35M
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-195.21%-4.07M
-155.76%-2.79M
5,030.38%16.71M
9.18%-267K
-19,823.60%-17.73M
709.40%4.28M
26,215.79%5M
-37.80%-339K
-27.27%-294K
63.52%-89K
Financing cash flow
Cash flow from continuing financing activities
3,189.05%70.28M
6,641.21%71.43M
-61.21%-453K
56.14%-282K
-61.78%-419K
92.64%-2.28M
-107.93%-1.09M
99.36%-281K
-80.11%-643K
52.30%-259K
Net issuance payments of debt
39.83%-1.58M
80.40%-253K
-5.09%-454K
54.56%-294K
-124.32%-581K
94.16%-2.63M
-259.61%-1.29M
99.01%-432K
-81.23%-647K
55.03%-259K
Net common stock issuance
--71.64M
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
-37.01%223K
-75.88%48K
-99.34%1K
200.00%12K
--162K
941.18%354K
19,800.00%199K
--151K
--4K
--0
Cash from discontinued financing activities
Financing cash flow
3,189.05%70.28M
6,641.21%71.43M
-61.21%-453K
56.14%-282K
-61.78%-419K
92.64%-2.28M
-107.93%-1.09M
99.36%-281K
-80.11%-643K
52.30%-259K
Net cash flow
Beginning cash position
25.48%118.93M
-25.84%89.4M
-38.57%78.97M
-38.33%85.71M
25.48%118.93M
-49.46%94.78M
20.03%120.55M
-17.80%128.56M
-17.08%138.99M
-49.46%94.78M
Current changes in cash
26.58%29.81M
4,293.35%59.29M
230.46%10.6M
39.69%-6.81M
-175.00%-33.28M
123.53%23.55M
65.09%-1.41M
86.31%-8.13M
26.88%-11.28M
308.79%44.38M
Effect of exchange rate changes
12.35%673K
434.74%713K
-246.61%-173K
-92.79%62K
142.77%71K
-91.85%599K
86.74%-213K
-96.52%118K
-79.63%860K
-112.37%-166K
End cash Position
25.63%149.41M
25.63%149.41M
-25.84%89.4M
-38.57%78.97M
-38.33%85.71M
25.48%118.93M
25.48%118.93M
20.03%120.55M
-17.80%128.56M
-17.08%138.99M
Free cash flow
-287.40%-37.81M
-60.04%-9.48M
24.26%-5.94M
38.70%-6.52M
-135.58%-15.86M
129.15%20.18M
66.76%-5.92M
49.73%-7.85M
29.41%-10.64M
315.29%44.59M
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -268.89%-36.39M-75.65%-9.35M24.65%-5.66M39.54%-6.26M-133.83%-15.13M131.45%21.55M70.16%-5.32M51.13%-7.51M30.30%-10.35M318.52%44.73M
Net income from continuing operations -0.10%-27.76M-69.71%-9.31M-49.59%-8.11M66.25%-2.69M13.52%-7.66M56.80%-27.74M58.77%-5.48M76.74%-5.42M40.84%-7.98M37.27%-8.86M
Operating gains losses 68.17%-345K-104.11%-79K91.34%-139K11.76%-195K110.15%68K59.93%-1.08M209.52%1.92M-140.01%-1.61M-256.45%-221K82.16%-670K
Depreciation and amortization 9.87%2.76M-7.83%671K7.17%688K19.70%711K25.87%691K-0.32%2.51M-2.67%728K4.90%642K0.51%594K-3.68%549K
Deferred tax -152.56%-197K--0--0---200K--3K-181.25%-78K--5K-220.29%-83K--0--0
Other non cash items 53.31%-2.81M76.64%-1.34M-29.20%-469K10.16%-513K-458.82%-488K-463.48%-6.01M-320.62%-5.72M39.40%-363K75.25%-571K-83.45%136K
Change In working capital -127.09%-13.26M-123.65%-543K155.63%1.12M-27.39%-4.61M-117.64%-9.22M1,080.89%48.96M141.27%2.3M-155.67%-2.01M-495.41%-3.62M1,423.80%52.29M
-Change in other working capital -127.09%-13.26M-123.65%-543K155.63%1.12M-27.39%-4.61M-117.64%-9.22M1,080.89%48.96M141.27%2.3M-155.67%-2.01M-495.41%-3.62M1,423.80%52.29M
Cash from discontinued investing activities
Operating cash flow -268.89%-36.39M-75.65%-9.35M24.65%-5.66M39.54%-6.26M-133.83%-15.13M131.45%21.55M70.16%-5.32M51.13%-7.51M30.30%-10.35M318.52%44.73M
Investing cash flow
Cash flow from continuing investing activities -195.21%-4.07M-155.76%-2.79M5,030.38%16.71M9.18%-267K-19,823.60%-17.73M709.40%4.28M26,215.79%5M-37.80%-339K-27.27%-294K63.52%-89K
Net PPE purchase and sale -8.16%-1.42M77.42%-133K15.63%-286K9.18%-267K-722.47%-732K-86.75%-1.31M-3,200.00%-589K-37.80%-339K-27.27%-294K63.52%-89K
Net intangibles purchase and sale --0------------------7.94M----------------
Net investment purchase and sale --0--0--17M--0---17M--0--0--0--0--0
Net other investing changes -12.93%-2.66M-------------------2.35M----------------
Cash from discontinued investing activities
Investing cash flow -195.21%-4.07M-155.76%-2.79M5,030.38%16.71M9.18%-267K-19,823.60%-17.73M709.40%4.28M26,215.79%5M-37.80%-339K-27.27%-294K63.52%-89K
Financing cash flow
Cash flow from continuing financing activities 3,189.05%70.28M6,641.21%71.43M-61.21%-453K56.14%-282K-61.78%-419K92.64%-2.28M-107.93%-1.09M99.36%-281K-80.11%-643K52.30%-259K
Net issuance payments of debt 39.83%-1.58M80.40%-253K-5.09%-454K54.56%-294K-124.32%-581K94.16%-2.63M-259.61%-1.29M99.01%-432K-81.23%-647K55.03%-259K
Net common stock issuance --71.64M------------------0----------------
Proceeds from stock option exercised by employees -37.01%223K-75.88%48K-99.34%1K200.00%12K--162K941.18%354K19,800.00%199K--151K--4K--0
Cash from discontinued financing activities
Financing cash flow 3,189.05%70.28M6,641.21%71.43M-61.21%-453K56.14%-282K-61.78%-419K92.64%-2.28M-107.93%-1.09M99.36%-281K-80.11%-643K52.30%-259K
Net cash flow
Beginning cash position 25.48%118.93M-25.84%89.4M-38.57%78.97M-38.33%85.71M25.48%118.93M-49.46%94.78M20.03%120.55M-17.80%128.56M-17.08%138.99M-49.46%94.78M
Current changes in cash 26.58%29.81M4,293.35%59.29M230.46%10.6M39.69%-6.81M-175.00%-33.28M123.53%23.55M65.09%-1.41M86.31%-8.13M26.88%-11.28M308.79%44.38M
Effect of exchange rate changes 12.35%673K434.74%713K-246.61%-173K-92.79%62K142.77%71K-91.85%599K86.74%-213K-96.52%118K-79.63%860K-112.37%-166K
End cash Position 25.63%149.41M25.63%149.41M-25.84%89.4M-38.57%78.97M-38.33%85.71M25.48%118.93M25.48%118.93M20.03%120.55M-17.80%128.56M-17.08%138.99M
Free cash flow -287.40%-37.81M-60.04%-9.48M24.26%-5.94M38.70%-6.52M-135.58%-15.86M129.15%20.18M66.76%-5.92M49.73%-7.85M29.41%-10.64M315.29%44.59M
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Tesla
TSLA
248.710
Apple
AAPL
218.270
Meta Platforms
META
596.250
4
Microsoft
MSFT
391.260
5
Petroleo Brasileiro SA Petrobras
PBR
14.160
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025